A Bioequivalence Study, Comparing Two Formulations of Ivermectin Lotion, 0.5%

Completed · Phase 1 · Has a placebo group

Conditions studied: Lice; Head Lice

In brief

A Multi-Center, Double-Blind, Randomized, Placebo controlled, Parallel-group study, comparing Ivermectin Lotion, 0.5%

Key facts

Study ID

NCT03257943

Run by

Sun Pharmaceutical Industries, Inc.

People needed

413

Starts

2017-03-20

Expected to finish

2017-08-18

Last updated by the study team

2018-05-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Subjects 18 years of age or older must have provided IRB-approved written informed consent and sign a HIPAA authorization.
• Subjects must be willing and able to understand and comply with the requirements of the protocol, including attendance at the required study visits.

You may not qualify if…

• Subjects with a history of hypersensitivity or allergy to or any component of the study product.
• Subject with history of irritation or sensitivity to pediculicides or hair care products.

Where it is running

• Taro Pharmaceuticals USA Inc. — Hawthorne, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.